{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:38:37Z","timestamp":1778031517455,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1124\/dmd.112.047118","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T09:28:35Z","timestamp":1342776515000},"page":"270-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy"],"prefix":"10.1016","volume":"41","author":[{"given":"Leslie J","family":"Dickmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Isoherranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.047118_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1468-1293.2008.00553.x","article-title":"Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics","volume":"9","author":"Capparelli","year":"2008","journal-title":"HIV Med"},{"key":"10.1124\/dmd.112.047118_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1124\/dmd.111.038679","article-title":"Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture","volume":"39","author":"Dickmann","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib3","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0090-9556(24)14960-4","article-title":"Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450","volume":"27","author":"Erickson","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.047118_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/JCP.0b013e31818d2048","article-title":"Pharmacokinetics of sertraline across pregnancy and postpartum","volume":"28","author":"Freeman","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.112.047118_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.112.047118_bib7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/mend.14.11.0547","article-title":"Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene","volume":"14","author":"Kawamoto","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.112.047118_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004714-199510000-00004","article-title":"Carbamazepine but not valproate induces bupropion metabolism","volume":"15","author":"Ketter","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.112.047118_bib9","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1124\/dmd.111.038646","article-title":"Complex drug interactions of HIV protease inhibitors 2: in vivo induction and in vitro to in vivo correlation of induction of cytochrome P450 1A2, 2B6, and 2C9 by ritonavir or nelfinavir","volume":"39","author":"Kirby","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2012.03.016","article-title":"Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy","volume":"84","author":"Koh","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0006-2952(00)00284-7","article-title":"Identification of the human cytochromes P450 involved in the oxidative metabolism of \u201cEcstasy\u201d-related designer drugs","volume":"59","author":"Kreth","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clpt.2006.03.010","article-title":"Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity","volume":"80","author":"Loboz","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.112.047118_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-200404000-00007","article-title":"Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis","volume":"26","author":"Maurer","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.112.047118_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920009789895534","article-title":"Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6","volume":"10","author":"Mo","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.112.047118_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1124\/mol.110.065540","article-title":"Regulation of CYP2C19 expression by estrogen receptor \u03b1: implications for estrogen-dependent inhibition of drug metabolism","volume":"78","author":"Mwinyi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/abbi.1995.1294","article-title":"Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes","volume":"319","author":"Nemoto","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.112.047118_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/clinchem\/37.5.667","article-title":"Longitudinal assessment of changes in reproductive hormones during normal pregnancy","volume":"37","author":"O\u2019Leary","year":"1991","journal-title":"Clin Chem"},{"key":"10.1124\/dmd.112.047118_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/dmd.104.002428","article-title":"Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study","volume":"33","author":"Obach","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.047118_bib20","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1124\/dmd.106.010132","article-title":"Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction","volume":"34","author":"Ripp","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1208\/s12248-008-9037-4","article-title":"Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical","volume":"10","author":"Sinz","year":"2008","journal-title":"AAPS J"},{"key":"10.1124\/dmd.112.047118_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.fertnstert.2005.02.045","article-title":"Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry","volume":"84","author":"Soldin","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1124\/dmd.112.047118_bib23","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","first-page":"1891","article-title":"Design and optimization of dosage regimens: pharmacokinetic data","author":"Thummel","year":"2011"},{"key":"10.1124\/dmd.112.047118_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.047118_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.112.047118_bib26","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0091270006293753","article-title":"Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6","volume":"46","author":"Walsky","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.2174\/138920008785821710","article-title":"CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme","volume":"9","author":"Wang","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.112.047118_bib28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/dmd.31.6.742","article-title":"Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.047118_bib29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.047118_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00228-005-0035-5","article-title":"Changes to methadone clearance during pregnancy","volume":"61","author":"Wolff","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib31","doi-asserted-by":"crossref","first-page":"37739","DOI":"10.1074\/jbc.R100033200","article-title":"Orphan nuclear receptors: the exotics of xenobiotics","volume":"276","author":"Xie","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.047118_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.2002.9366","article-title":"Estrogen-dependent regulation of the expression of hepatic Cyp2b and 3a isoforms: assessment using aromatase-deficient mice","volume":"180","author":"Yamada","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.047118_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jbt.2","article-title":"Localization of estradiol-responsive region in the phenobarbital-responsive enhancer module of mouse Cyp2b-10 gene","volume":"15","author":"Yamamoto","year":"2001","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.112.047118_bib34","first-page":"887","article-title":"Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes","volume":"29","author":"Yanagihara","year":"2001","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624116005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624116005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.047118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:40:58Z","timestamp":1739907658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624116005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0090955624116005"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.047118","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative Prediction of CYP2B6 Induction by Estradiol During Pregnancy: Potential Explanation for Increased Methadone Clearance During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.047118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}